WallStreetZenWallStreetZen

NASDAQ: KMTS
Kestra Medical Technologies Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for KMTS

Based on 5 analysts offering 12 month price targets for Kestra Medical Technologies Ltd

Min Forecast
$23.00-6.12%
Avg Forecast
$27.00+10.2%
Max Forecast
$29.00+18.37%

Should I buy or sell KMTS stock?

Based on 5 analysts offering ratings for Kestra Medical Technologies Ltd.

Strong Buy
Strong Buy
3 analysts 60%
Buy
1 analysts 20%
Hold
1 analysts 20%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although KMTS's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates KMTS as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their KMTS stock forecasts and price targets.

KMTS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-16
lockedlocked$00.00+00.00%2025-03-31
lockedlocked$00.00+00.00%2025-03-31
lockedlocked$00.00+00.00%2025-03-31
lockedlocked$00.00+00.00%2025-03-31

1 of 1

Forecast return on equity

Is KMTS forecast to generate an efficient return?

Insufficient data to display

Forecast return on assets

Is KMTS forecast to generate an efficient return on assets?

Company
-34%
Industry
5.42%
KMTS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KMTS earnings per share forecast

What is KMTS's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$1.90
Avg 2 year Forecast
-$1.94
Avg 3 year Forecast
-$2.02

KMTS revenue forecast

What is KMTS's revenue in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
$82.9M
Avg 2 year Forecast
$126.3M
Avg 3 year Forecast
$187.5M

KMTS vs Medical Stocks

TickerPricePrice TargetUp/downsideConsensus
KMTS$24.50$27.00+10.20%Strong Buy
AZTA$26.61$57.00+114.21%Buy
PLSE$17.80N/AN/A
BLFS$24.71$30.57+23.72%Strong Buy
STAA$18.54$17.50-5.61%Buy
View Top Medical Stocks

Kestra Medical Technologies Stock Forecast FAQ

Is Kestra Medical Technologies Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 5 Wall Street analysts covering (NASDAQ: KMTS) stock is to Strong Buy KMTS stock.

Out of 5 analysts, 3 (60%) are recommending KMTS as a Strong Buy, 1 (20%) are recommending KMTS as a Buy, 1 (20%) are recommending KMTS as a Hold, 0 (0%) are recommending KMTS as a Sell, and 0 (0%) are recommending KMTS as a Strong Sell.

If you're new to stock investing, here's how to buy Kestra Medical Technologies stock.

What is KMTS's earnings growth forecast for 2025-2026?

(NASDAQ: KMTS) Kestra Medical Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 17.61%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.6%.

Kestra Medical Technologies's earnings in 2025 is N/A.On average, 1 Wall Street analyst forecast KMTS's earnings for 2025 to be -$97,562,446, with the lowest KMTS earnings forecast at -$97,562,446, and the highest KMTS earnings forecast at -$97,562,446. On average, 3 Wall Street analysts forecast KMTS's earnings for 2026 to be -$99,446,942, with the lowest KMTS earnings forecast at -$103,724,285, and the highest KMTS earnings forecast at -$94,995,014.

In 2026, KMTS is forecast to generate -$103,724,285 in earnings, with the lowest earnings forecast at -$103,724,285 and the highest earnings forecast at -$103,724,285.

What is KMTS's revenue growth forecast for 2026-2028?

(NASDAQ: KMTS) Kestra Medical Technologies's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast revenue growth rate of 9.76%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.18%.

Kestra Medical Technologies's revenue in 2025 is N/A.On average, 2 Wall Street analysts forecast KMTS's revenue for 2026 to be $4,254,749,636, with the lowest KMTS revenue forecast at $4,231,129,254, and the highest KMTS revenue forecast at $4,278,370,018. On average, 2 Wall Street analysts forecast KMTS's revenue for 2027 to be $6,482,767,820, with the lowest KMTS revenue forecast at $6,475,579,008, and the highest KMTS revenue forecast at $6,489,956,632.

In 2028, KMTS is forecast to generate $9,626,589,284 in revenue, with the lowest revenue forecast at $9,589,874,995 and the highest revenue forecast at $9,663,303,573.

What is KMTS's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: KMTS) forecast ROA is -34%, which is lower than the forecast US Medical Instruments & Supplies industry average of 5.42%.

What is KMTS's Price Target?

According to 5 Wall Street analysts that have issued a 1 year KMTS price target, the average KMTS price target is $27.00, with the highest KMTS stock price forecast at $29.00 and the lowest KMTS stock price forecast at $23.00.

On average, Wall Street analysts predict that Kestra Medical Technologies's share price could reach $27.00 by Apr 16, 2026. The average Kestra Medical Technologies stock price prediction forecasts a potential upside of 10.2% from the current KMTS share price of $24.50.

What is KMTS's Earnings Per Share (EPS) forecast for 2025-2026?

(NASDAQ: KMTS) Kestra Medical Technologies's current Earnings Per Share (EPS) is N/A. On average, analysts forecast that KMTS's EPS will be -$1.90 for 2025, with the lowest EPS forecast at -$1.90, and the highest EPS forecast at -$1.90. On average, analysts forecast that KMTS's EPS will be -$1.94 for 2026, with the lowest EPS forecast at -$2.02, and the highest EPS forecast at -$1.85. In 2026, KMTS's EPS is forecast to hit -$2.02 (min: -$2.02, max: -$2.02).

What is KMTS's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: KMTS) forecast ROE is N/A, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.